These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32526321)

  • 1. Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma.
    Marchetti MA; Dusza SW; Bartlett EK
    J Am Acad Dermatol; 2020 Nov; 83(5):e357-e358. PubMed ID: 32526321
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma.
    Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
    J Am Acad Dermatol; 2020 Nov; 83(5):e359-e360. PubMed ID: 32526325
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing Genetic Expression Profiles in Melanoma Prognosis.
    Farberg AS; Glazer AM; Winkelmann RR; Rigel DS
    Dermatol Clin; 2017 Oct; 35(4):545-550. PubMed ID: 28886811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling in melanoma: past results and future potential.
    Knackstedt RW; Knackstedt T; Gastman B
    Future Oncol; 2019 Mar; 15(7):791-800. PubMed ID: 30453756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Genetic Expression Profiles in Melanoma Diagnosis.
    Leachman SA; Mengden Koon S; Korcheva VB; White KP
    Dermatol Clin; 2017 Oct; 35(4):537-544. PubMed ID: 28886810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using 31-Gene Expression Profile in Melanoma Risk Prognosis.
    Vasile G; Ilyas M; Lazzara D; Jacobs D; Matin T; Saleeby E; Weiss E
    J Drugs Dermatol; 2021 May; 20(5):585-586. PubMed ID: 33938695
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular Profiling in Cutaneous Melanoma.
    Ji AL; Bichakjian CK; Swetter SM
    J Natl Compr Canc Netw; 2016 Apr; 14(4):475-80. PubMed ID: 27059194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Expression Profiling for Melanoma Prognosis: Going Beyond What We See With Our Eyes.
    Ngo BT
    Cutis; 2023 May; 111(5):222-223. PubMed ID: 37406321
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
    Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
    J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of new molecular tests for melanoma by pigmented-lesion experts.
    Varedi A; Gardner LJ; Kim CC; Chu EY; Ming ME; Leachman SA; Curiel-Lewandrowski C; Swetter SM; Grossman D
    J Am Acad Dermatol; 2020 Jan; 82(1):245-247. PubMed ID: 31415835
    [No Abstract]   [Full Text] [Related]  

  • 11. The prognostic potential of alternative transcript isoforms across human tumors.
    Trincado JL; Sebestyén E; Pagés A; Eyras E
    Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating Skin Cancer-Related Technologies into Clinical Practice.
    Winkelmann RR; Farberg AS; Glazer AM; Cockerell CJ; Sober AJ; Siegel DM; Leachman SA; High WA; Markowitz O; Berman B; Pariser DM; Goldenberg G; Rosen T; Rigel DS
    Dermatol Clin; 2017 Oct; 35(4):565-576. PubMed ID: 28886814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test.
    Mirsky R; Prado G; Svoboda R; Glazer A; Rigel D
    J Drugs Dermatol; 2018 Nov; 17(11):1220-1223. PubMed ID: 30500144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular techniques for predicting behaviour in melanocytic neoplasms.
    Lee CY; Gerami P
    Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients.
    Cook RW; Middlebrook B; Wilkinson J; Covington KR; Oelschlager K; Monzon FA; Stone JF
    Diagn Pathol; 2018 Feb; 13(1):13. PubMed ID: 29433548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spitz nevi in older adults: Correlation of histopathology with results of a gene expression profiling assay.
    Friedman BJ; Lee JB
    J Am Acad Dermatol; 2020 Apr; 82(4):1021-1023. PubMed ID: 31866264
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
    High WA
    Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early diagnosis is crucial for prognosis of skin melanoma].
    Hägermark O; Beither H; Hedblad MA; Landegren J
    Lakartidningen; 1997 Oct; 94(42):3705-6. PubMed ID: 9411120
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant melanoma: early detection and prognosis].
    Wolff K; Pehamberger H
    Wien Klin Wochenschr; 1985 May; 97(10):451-5. PubMed ID: 4013340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.